Merrimack Pharmaceuticals Board of Directors, Key People and Executives

Health Care & Life Sciences » Pharmaceuticals | Merrimack Pharmaceuticals Inc.

Merrimack Pharmaceuticals Inc. | Key People and Executives

Richard Peters

President, Chief Executive Officer & Director

Gary L. Crocker

Chairman

George D. Demetri

Independent Director

John M. Dineen

Independent Director

Russ T. Ray

Independent Director

Ulrik B. Nielsen

Independent Director

James H. Quigley

Independent Director

Richard Peters

President, Chief Executive Officer & Director

Jeffrey A. Munsie

Secretary, Head-Operations & General Counsel

Jean M. Franchi

CFO, Treasurer & Principal Accounting Officer

Sergio L. Santillana

Chief Medical Officer

Daryl Drummond

Head-Research

Geoffrey M. Grande

Investor Relations & Media Contact

Ellen K. Forest

Head-Human Resources

Gary L. Crocker

Chairman

George D. Demetri

Independent Director

John M. Dineen

Independent Director

Russ T. Ray

Independent Director

Ulrik B. Nielsen

Independent Director

James H. Quigley

Independent Director

View Profile

Address	One Broadway Cambridge Massachusetts 02142 United States
Employees	-
Website	http://www.merrimackpharma.com
Updated	07/08/2019
Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J.